DALLAS, February 19, 2025--Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of ...

Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology drug discovery and ...

These forward-looking statements include, among other things, statements relating to: the potential advantages of our novel machine learning solution for predicting blood-brain barrier (BBB) ...

As the wave of digitalization sweeps across industries, patents and technological achievements are increasingly valued, with PCT international patent applications becoming a key indicator of ...

WESTMINSTER, Colo., Aug. 09, 2021 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted ...

The patent is based on novel research discoveries from the laboratory of Univ.-Prof. Dr. Wolfram Ruf, at the Center for Thrombosis and Hemostasis (CTH) of the University Medical Center Mainz, Germany.

PCT International has received a new coaxial cable patent from the USPTO, patent #US11,037,703. This innovative patent provides enhanced shielding tap ...